Participated · Equity · Jan 2023

Biohm is a Cleveland, OH-based microbiome company that leverages microbiome data to create products and ingredients intended to improve individual health. Its product lineup includes the BIOHM FX probiotic supplement designed to reduce digestive plaque, additional probiotic and prebiotic supplements, and a personalized Gut Test. The company raised $7.5M in equity financing to support growth. Biohm plans to use the funds to fast-track development of A.I. technology and targeted, data-driven microbiome formulations. The company is led by CEO Afif Ghannoum and President Sam Schatz. Biohm Health is a microbiome company that applies a proprietary dual-action technology to neutralize harmful bacteria and fungi and deliver a probiotic designed to break down digestive plaque while maintaining overall microbiome balance. The company sells probiotics and other gut-health products and offers The BIOHM Gut Report, a test that identifies and measures gut bacteria and fungi and provides personalized, actionable wellness recommendations including nutritional advice. The business is led by CEO Afif Ghannoum and was founded by Afif Ghannoum and Dr. Mahmoud Ghannoum following their discovery that bad bacteria and bad fungus collaborate to create digestive imbalance. Biohm is based in Cleveland, OH. In December 2017 the company raised funding from Vanterra Capital; the terms of the investment were not disclosed. As part of the deal, Vanterra will join BIOHM's board alongside the founders.

Led · Seed · Feb 2020

MedPilot builds a patient financial relationship platform that transforms patient billing through customized outreach tailored to patients’ communication preferences. The platform leverages emails, texts, calls, and statements and uses machine learning to optimize outreach based on patient interactions. It supplies tools for healthcare providers’ billing departments and revenue cycle management companies to track patients, manage experience, and monitor financial activity. MedPilot has helped over 1 million patients to date and reports a 97% patient satisfaction score. The company says it will use new funding to fuel its next stage of growth and continue modernizing the patient billing experience. MedPilot provides a patient financial engagement platform used by outpatient facilities, hospitals, revenue cycle management companies, and practice management systems. The platform combines millions of data points from clients' practice management systems with internally derived insights and analytics to personalize communication method, content, and payment options. Using machine learning, MedPilot continuously optimizes outreach strategies based on patient interactions and also provides administrative tools to track patients, manage experience, and monitor financial activity. The company is led by co-founder and CEO Jacob Myers and COO Nathan Spoden and is based in Cleveland, Ohio. MedPilot graduated in the latest class of the Cedars-Sinai Accelerator. It completed a $1.7M seed funding round to bolster the team and launch new functionality to further engage patients throughout their lifecycle. MedPilot provides a performance-analytics platform that gives healthcare providers insight into the most effective billing and collections outreach by tracking sent rate, open rate, click rate, and response time. The software uses patient demographics, payment history and behavioral-economics data to craft tailored payment-resolution strategies and optimize outreach content. It integrates with providers’ internal billing and collections teams and also collaborates with third-party collectors such as Retrieval Masters Creditors Bureau. The company says it will use new funding to invest in technology, sales and marketing, and to support operational costs. Co-founder Matthew Buder Shapiro has a background in digital marketing and emphasized allocating manual touch where needed and digital approaches where effective. MedPilot participated in Blueprint Health’s accelerator and is based in New York. The company raised $750,000 in a Seed round to support these plans.